ROHTO PHARMACEUTICAL COROHTO PHARMACEUTICAL COROHTO PHARMACEUTICAL CO

ROHTO PHARMACEUTICAL CO

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪785.39 B‬JPY
‪30.94 B‬JPY
‪270.84 B‬JPY
‪174.98 M‬
Beta (1Y)
0.40
Employees (FY)
‪7.26 K‬
Change (1Y)
+83 +1.16%
Revenue / Employee (1Y)
‪246.51 K‬JPY
Net income / Employee (1Y)
‪28.16 K‬JPY

About ROHTO PHARMACEUTICAL CO


Headquarters
Osaka
Founded
1899
ISIN
JP3982400008
FIGI
BBG000BJXWF2
Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4527 is 3,383 JPY — it has decreased by −0.21% in the past 24 hours. Watch ROHTO PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ROHTO PHARMACEUTICAL CO stocks are traded under the ticker 4527.
4527 stock has fallen by −0.24% compared to the previous week, the month change is a −5.24% fall, over the last year ROHTO PHARMACEUTICAL CO has showed a −4.06% decrease.
We've gathered analysts' opinions on ROHTO PHARMACEUTICAL CO future price: according to them, 4527 price has a max estimate of 4,770.00 JPY and a min estimate of 3,600.00 JPY. Watch 4527 chart and read a more detailed ROHTO PHARMACEUTICAL CO stock forecast: see what analysts think of ROHTO PHARMACEUTICAL CO and suggest that you do with its stocks.
4527 reached its all-time high on Sep 15, 2023 with the price of 4,117 JPY, and its all-time low was 170 JPY and was reached on Dec 18, 2001. View more price dynamics on 4527 chart.
See other stocks reaching their highest and lowest prices.
4527 stock is 1.54% volatile and has beta coefficient of 0.40. Track ROHTO PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is ROHTO PHARMACEUTICAL CO there?
Today ROHTO PHARMACEUTICAL CO has the market capitalization of ‪771.79 B‬, it has increased by 2.52% over the last week.
Yes, you can track ROHTO PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
ROHTO PHARMACEUTICAL CO is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
4527 earnings for the last quarter are 37.18 JPY per share, whereas the estimation was 39.89 JPY resulting in a −6.79% surprise. The estimated earnings for the next quarter are 35.07 JPY per share. See more details about ROHTO PHARMACEUTICAL CO earnings.
ROHTO PHARMACEUTICAL CO revenue for the last quarter amounts to ‪68.36 B‬ JPY, despite the estimated figure of ‪67.66 B‬ JPY. In the next quarter, revenue is expected to reach ‪71.02 B‬ JPY.
4527 net income for the last quarter is ‪8.48 B‬ JPY, while the quarter before that showed ‪4.78 B‬ JPY of net income which accounts for 77.51% change. Track more ROHTO PHARMACEUTICAL CO financial stats to get the full picture.
ROHTO PHARMACEUTICAL CO dividend yield was 0.91% in 2023, and payout ratio reached 19.91%. The year before the numbers were 0.79% and 19.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has ‪7.26 K‬ employees. See our rating of the largest employees — is ROHTO PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROHTO PHARMACEUTICAL CO EBITDA is ‪49.06 B‬ JPY, and current EBITDA margin is 18.04%. See more stats in ROHTO PHARMACEUTICAL CO financial statements.
Like other stocks, 4527 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROHTO PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROHTO PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROHTO PHARMACEUTICAL CO stock shows the buy signal. See more of ROHTO PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.